Literature DB >> 9563984

Inappropriate use of sumatriptan: population based register and interview study.

D Gaist1, I Tsiropoulos, S H Sindrup, J Hallas, B K Rasmussen, J Kragstrup, L F Gram.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9563984      PMCID： PMC28533          DOI： 10.1136/bmj.316.7141.1352

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Is overuse of sumatriptan a problem? A population-based study.

Authors:  D Gaist; J Hallas; S H Sindrup; L F Gram
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

2.  The Danish prescription registries.

Authors:  D Gaist; H T Sørensen; J Hallas
Journal:  Dan Med Bull       Date:  1997-09

3.  Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.

Authors: 
Journal:  Cephalalgia       Date:  1988       Impact factor: 6.292

4.  Use of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data.

Authors:  D Gaist; M Andersen; A L Aarup; J Hallas; L F Gram
Journal:  Br J Clin Pharmacol       Date:  1997-04       Impact factor: 4.335

5.  Presentation of a new instrument: the diagnostic headache diary.

Authors:  M B Russell; B K Rasmussen; J Brennum; H K Iversen; R A Jensen; J Olesen
Journal:  Cephalalgia       Date:  1992-12       Impact factor: 6.292
  5 in total
  9 in total

Review 1.  Medication overuse headache: a focus on analgesics, ergot alkaloids and triptans.

Authors:  Z Katsarava; H C Diener; V Limmroth
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis.

Authors:  Andrew J Dowson; David W Dodick; Volker Limmroth
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Sumatriptan is not the only analgesic used inappropriately.

Authors:  P J Goadsby
Journal:  BMJ       Date:  1998-10-10

4.  Neuroendocrine effects of subcutaneous sumatriptan in patients with migraine.

Authors:  I Rainero; W Valfrè; L Savi; S Gentile; L Pinessi; L Gianotti; E Arvat; E Ghigo; P Del Rizzo; P Calvelli; P Limone
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

5.  Drug dependence associated with triptans and ergot derivatives: a case/non-case study.

Authors:  Frédérique Beau-Salinas; Annie Pierre Jonville-Béra; Haware Cissoko; Lamiae Bensouda-Grimaldi; Elisabeth Autret-Leca
Journal:  Eur J Clin Pharmacol       Date:  2009-12-19       Impact factor: 2.953

6.  Tension-type Headache.

Authors:  Rigmor Jensen
Journal:  Curr Treat Options Neurol       Date:  2001-03       Impact factor: 3.972

Review 7.  Analgesic/abortive overuse and misuse in chronic daily headache.

Authors:  H C Diener; Z Katasarva
Journal:  Curr Pain Headache Rep       Date:  2001-12

Review 8.  Medication-overuse headache.

Authors:  Lutz Pageler; Irini Savidou; Volker Limmroth
Journal:  Curr Pain Headache Rep       Date:  2005-12

9.  Perinatal use of triptans and other drugs for migraine-A nationwide drug utilization study.

Authors:  Fatima Tauqeer; Mollie Wood; Sarah Hjorth; Angela Lupattelli; Hedvig Nordeng
Journal:  PLoS One       Date:  2021-08-23       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.